Strategic Planning
The struggle is that "you can't just plop something in the middle of a system even though it has good effectiveness and expect people to change their behavior or trust it," says Dr. Cole Zanetti at Rocky Vista University College of Osteopathic Medicine.
During an EHR transition, it is essential to keep the patient at the center of the transition, ensuring collaboration with clinicians and patients is done early, says Epic Emeritus CIO Kelli Garrison, founder and CEO of Verdant Consulting.
Event attendees explored the challenges and benefits of AI while learning about governance, leadership strategy, workforce challenges, transparency, patient safety and data security at the gathering in Brooklyn, New York.
Hippocratic’s generative AI agents will be used to free up providers so they can focus on their patients.
HIMSS25
With healthcare spending, particularly for Medicare Advantage, under scrutiny, 1upHealth's Dr. Don Rucker says AI-ready, open API platforms that can integrate and analyze disparate data are needed to inform care and control costs.
In response to a new price cap law in Indiana, Hal Andrews, CEO of Trilliant Health, says once a state legislature is allowed to determine maximum reimbursement, hospitals are subject to that being changed any time the legislature gets together.
HIMSS25
Edward Marx, CEO of Marx Advisory, recommends that healthcare leaders looking to drive innovation in their organizations become innovative themselves by bringing their C-suite to meet with and learn from partners.
HIMSS25
Regina Wysocki, senior informatics program manager at Lone Star Communications, says centralizing health system data provides nurses with a "bigger picture" of operations so they can uncover trends that can improve care delivery.
Through working with global leaders, educating its members and developing digital transformation tools for health systems, Hal Wolf, HIMSS president and CEO, says HIMSS encourages the ethical and practical integration of AI in healthcare.
Morgan Cheatham, partner and head of healthcare and life sciences at Breyer Capital, provides highlights of the venture capital firm's strategy when funding emerging technologies and the risks associated with backing these innovations.